Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07524361 · ClinicalTrials.gov registry record · Early Phase 1

Taekwondo Program for Preventing Falls in Older Adults

A Early Phase 1 study, sponsored by University of South Carolina.

Active
Registry status
Early Phase 1
Development phase
20
Enrollment target

NCT07524361 is a Early Phase 1 study that is active but no longer recruiting, run by University of South Carolina. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07524361, a Early Phase 1 study, is active but no longer recruiting, sponsored by University of South Carolina.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
20 participants
Enrollment target

Study Summary

Falls in older adults are a public health crisis, as 30% of older adults fall each year, with a mortality rate of 78%.1 Fall-related healthcare costs are over 50 billion dollars.1 Therefore, preventing older adults from falling is important in both individual and public health aspects by increasing their quality of life and reducing healthcare costs. However, the current fall-prevention exercise programs have a limitation in maintaining exercise adherence behaviors or increasing physical activities once the intervention is completed.2 The theory-based exercise program shows a higher adherence and retention rate.3,4 Taekwondo (TKD), one type of martial arts, can be a potential channel to deliver a theory-based fall prevention exercise program. Therefore, this study aims to test the feasibility of the potential 12 Taekwondo-based fall prevention exercise program for older adults and its preliminary efficacy using a randomized controlled trial.

Interventions

  • BEHAVIORAL Fall prevention exercise using Taekwondo
  • BEHAVIORAL Live Strong and Safe Program on Fall Prevention

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-01-13
Est. Completion 2026-12-31
Phase Early Phase 1

Sponsor

University of South Carolina

157 total trials

What the Registry Record Tells You About NCT07524361

The ClinicalTrials.gov registry entry for NCT07524361 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Fall prevention exercise using Taekwondo is the first listed.

NCT07524361 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07524361 about?

NCT07524361 is a clinical study titled "Taekwondo Program for Preventing Falls in Older Adults". Falls in older adults are a public health crisis, as 30% of older adults fall each year, with a mortality rate of 78%.1 Fall-related healthcare costs are over 50 billion dollars.1 Therefore, preventing older adults from falling is important in both individual and public health aspects by increasing ...

What is the current status of trial NCT07524361?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2026-01-13. Estimated completion is 2026-12-31.

What interventions are being tested in trial NCT07524361?

The interventions under investigation include: Fall prevention exercise using Taekwondo (BEHAVIORAL), Live Strong and Safe Program on Fall Prevention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07524361?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.